Kisspeptin-10 inhibits OHSS by suppressing VEGF secretion.

The aim of the present study was to elucidate the effects of kisspeptin-10 (Kp-10) on ovarian hyperstimulation syndrome (OHSS) and its related mechanism in OHSS rat models， human umbilical vein endothelial cells (HUVECs) and human luteinized granulosa cells. OHSS is a systemic disorder with high vascular permeability (VP) and ovarian enlargement. KISS1R (KISS1 receptor) is the specific receptor of kisspeptin. The kisspeptin/KISS1R system inhibits the expression of vascular endothelial growth factor (VEGF)， which is the main regulator of VP. In our study， decreased expression of Kiss1r was observed in both ovaries and lung tissue of OHSS rats. Injection of exogenous Kp-10 inhibited the increase of VP and VEGF while promoting the expression of Kiss1r in both the ovarian and lung tissue of OHSS rats. Using HUVECs， we revealed that a high level of 17-β estradiol (E)， a feature of OHSS， suppressed the expression of KISS1R and increased VEGF and nitric oxide (NO) through estrogen receptors (ESR2). Furthermore， mRNA also decreased in the luteinized human granulosa cells of high-risk OHSS patients， and was consistent with the results in rat models and HUVECs. In conclusion， Kp-10 prevents the increased VP of OHSS by the activation of KISS1R and the inhibition of VEGF.